Capacity expansion for major Pharma’s hormonal disorders and women’s health portfolio

We’re proud to announce a capacity expansion at our Braine-l’Alleud site in Belgium, strategically backed by customer financing. This investment underscores our commitment to capturing growth in the dynamic global peptide market.

What this means:
✅ Advanced process equipment for highly complex peptides
✅ Strict environmental control capabilities for demanding modalities
✅ Multi-year commercial contract securing long-term partnership
✅ Enhanced end-to-end support from development to commercial supply

“From early development to commercial supply, we’ve been in close collaboration with our client every step of the way,” shares Stéphane Varray, our Chief Commercial Officer. “This investment demonstrates our strong partnership with our long-standing customer and our commitment to drive long-term growth.”

This expansion further solidifies PolyPeptide’s position as a trusted CDMO partner for complex peptide therapeutics worldwide.